CD8A and relapsing-remitting multiple sclerosis: At this juncture, relapsing–remitting MS (RRMS) can ensue to generate characteristic lesions, dominated by outbreaks of viral reactivation and CD8+T-cell-mediated cytotoxicity and inflammation.